C

Carmell Therapeutics

18 employees

Carmell develops technology for producing biologically-active plastics from blood plasma for treating bone and connective tissue injuries.

Basic info

Industry

biotechnology research

Sectors

Research and Development
Biotechnology
Medical Device
Biotech
Orthobiologics
Pharmaceutical
Clinical Development
Regenerative Medicine
Health Care
Technology
Therapeutics
Life Science

Date founded

2007

Funding rounds raised

Total raised

$4M

from 22 investors over 22 rounds

C

Carmell Therapeutics raised undisclosed on September 29, 2022

Investors: Keiretsu Capital

C

Carmell Therapeutics raised $50K on June 24, 2020

Investors: Innovation Works

C

Carmell Therapeutics raised $50K on June 24, 2020

Investors: Innovation Works

C

Carmell Therapeutics raised undisclosed on June 30, 2019

Investors: Keiretsu Capital

C

Carmell Therapeutics raised $4M on July 11, 2017

Investors: Newlin Investment, Maine Angels, Keiretsu Capital, BlueTree Allied Angels, Keiretsu Forum / Capital and Harbor Light Captial Partners

C

Carmell Therapeutics raised $50K on January 6, 2015

Investors: Lehigh Valley Angel Investors

C

Carmell Therapeutics raised $304K on November 12, 2014

Investors: Innovation Works

C

Carmell Therapeutics raised $682K on June 13, 2014

Investors: Pittsburgh Life Sciences Greenhouse, BlueTree Allied Angels, Harbor Light Captial Partners and Innovation Works

C

Carmell Therapeutics raised $2.4M on April 18, 2011

Investors: Newlin Investment, Ariel Savannah Angel Partners, Harbor Light Captial Partners, Pittsburgh Life Sciences Greenhouse, Innovation Works and BlueTree Allied Angels

FAQ